AUPH vs OKE · P/E 28, rev $283.1M vs P/E 15, rev $21.70B
Aurinia Pharmaceuticals Inc (AUPH) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the AUPH and OKE stock pages for the full models.
Not investment advice.